Skip to main content

Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025

Bristol Myers Squibb (NYSE: BMY) today reported fourth quarter and full-year 2025 financial results.

Visit the company’s Investor Relations website at http://investor.bms.com to view the detailed fourth quarter and full-year 2025 earnings press release and investor presentation.

The company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. ET today, February 5, 2026, which is accessible here. Company executives will review financial results with the investment community during the call.

A replay of the webcast will be available at http://investor.bms.com approximately three hours after the conference call concludes.

About Bristol Myers Squibb: Transforming Patients' Lives Through Science

At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what's possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com and follow us on LinkedIn, X, YouTube, Facebook and Instagram.

corporatefinancial-news

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  232.99
+0.00 (0.00%)
AAPL  276.49
+0.00 (0.00%)
AMD  200.19
+0.00 (0.00%)
BAC  55.38
+0.00 (0.00%)
GOOG  333.34
+0.00 (0.00%)
META  668.99
+0.00 (0.00%)
MSFT  414.19
+0.00 (0.00%)
NVDA  174.19
+0.00 (0.00%)
ORCL  146.67
+0.00 (0.00%)
TSLA  406.01
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.